Robert E. Mosser

Array ( [id] => 4965766 [patent_doc_number] => 20080108586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'COMBINATION THERAPY FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 11/850238 [patent_app_country] => US [patent_app_date] => 2007-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14331 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108586.pdf [firstpage_image] =>[orig_patent_app_number] => 11850238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223147 [patent_doc_number] => 20100056570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'FUNGICIDES' [patent_app_type] => utility [patent_app_number] => 12/439834 [patent_app_country] => US [patent_app_date] => 2007-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26629 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056570.pdf [firstpage_image] =>[orig_patent_app_number] => 12439834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324401 [patent_doc_number] => 20090062391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Use of a virucidal ointment in the nares for prevention of transmission and contraction of common colds' [patent_app_type] => utility [patent_app_number] => 11/845756 [patent_app_country] => US [patent_app_date] => 2007-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2466 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062391.pdf [firstpage_image] =>[orig_patent_app_number] => 11845756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6355544 [patent_doc_number] => 20100022482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'aSMase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/438437 [patent_app_country] => US [patent_app_date] => 2007-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20938 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022482.pdf [firstpage_image] =>[orig_patent_app_number] => 12438437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4799706 [patent_doc_number] => 20080011293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Stable Xylometazoline and Oxymetazoline Solution' [patent_app_type] => utility [patent_app_number] => 11/840778 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2713 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20080011293.pdf [firstpage_image] =>[orig_patent_app_number] => 11840778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899869 [patent_doc_number] => 20080119483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING PROTOZOAN GROWTH' [patent_app_type] => utility [patent_app_number] => 11/840741 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19316 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119483.pdf [firstpage_image] =>[orig_patent_app_number] => 11840741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375883 [patent_doc_number] => 08680148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Metallo-desferrioxamine complexes and their use in the treatment of bacterial infections' [patent_app_type] => utility [patent_app_number] => 11/838177 [patent_app_country] => US [patent_app_date] => 2007-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 47 [patent_no_of_words] => 9305 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11838177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4746223 [patent_doc_number] => 20080090825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Metallo-beta-lactamase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/889296 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30779 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090825.pdf [firstpage_image] =>[orig_patent_app_number] => 11889296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9323165 [patent_doc_number] => 08658183 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-25 [patent_title] => 'Antimicrobial parenteral formulation' [patent_app_type] => utility [patent_app_number] => 11/836241 [patent_app_country] => US [patent_app_date] => 2007-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6399 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11836241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6237063 [patent_doc_number] => 20100267827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'PHENYL-PRENYL-ETHER DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/375607 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12685 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267827.pdf [firstpage_image] =>[orig_patent_app_number] => 12375607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6402103 [patent_doc_number] => 20100179205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'Composition for Enhanced Antiparasitic Activity' [patent_app_type] => utility [patent_app_number] => 12/376514 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2356 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20100179205.pdf [firstpage_image] =>[orig_patent_app_number] => 12376514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10533810 [patent_doc_number] => 09259426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => '4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections' [patent_app_type] => utility [patent_app_number] => 12/374433 [patent_app_country] => US [patent_app_date] => 2007-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 41284 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12374433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4910308 [patent_doc_number] => 20080021075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Treatment of Pain' [patent_app_type] => utility [patent_app_number] => 11/780088 [patent_app_country] => US [patent_app_date] => 2007-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5116 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20080021075.pdf [firstpage_image] =>[orig_patent_app_number] => 11780088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294515 [patent_doc_number] => 08222296 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Conjugates comprising a GABA- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating CNS disorders' [patent_app_type] => utility [patent_app_number] => 12/373542 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13956 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12373542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016657 [patent_doc_number] => 20070259866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Method of Adenovirus, HIV and HPV Prophylaxis' [patent_app_type] => utility [patent_app_number] => 11/778706 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7416 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259866.pdf [firstpage_image] =>[orig_patent_app_number] => 11778706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368524 [patent_doc_number] => 20090306083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Use of Trifluoromethyl Substituted Benzamides in teh Treatment of Neurological Disorders' [patent_app_type] => utility [patent_app_number] => 12/373592 [patent_app_country] => US [patent_app_date] => 2007-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15709 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306083.pdf [firstpage_image] =>[orig_patent_app_number] => 12373592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558863 [patent_doc_number] => 20090270440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'BIOAVAILABILITY OF ACTIVE SUBSTANCES HAVING AN AMIDINE FUNCTION IN MEDICAMENTS' [patent_app_type] => utility [patent_app_number] => 12/374300 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1800 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270440.pdf [firstpage_image] =>[orig_patent_app_number] => 12374300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4575418 [patent_doc_number] => 07825143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Method for controlling the yeast-to-filamentous growth transition in fungi' [patent_app_type] => utility [patent_app_number] => 11/775852 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4750 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/825/07825143.pdf [firstpage_image] =>[orig_patent_app_number] => 11775852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629357 [patent_doc_number] => 20100004268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Optically Pure Dihydropyrimidine Compounds and Their Uses for the Preparation of a Medicament for Treatment and Prevention of Viral Diseases' [patent_app_type] => utility [patent_app_number] => 12/373101 [patent_app_country] => US [patent_app_date] => 2007-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7523 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004268.pdf [firstpage_image] =>[orig_patent_app_number] => 12373101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5015885 [patent_doc_number] => 20070259094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'N-acetylglucosamine as a food and beverage additive' [patent_app_type] => utility [patent_app_number] => 11/822557 [patent_app_country] => US [patent_app_date] => 2007-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7891 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259094.pdf [firstpage_image] =>[orig_patent_app_number] => 11822557 [rel_patent_id] =>[rel_patent_doc_number] =>)